BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20501426)

  • 1. [Value of tumor markers in the cerebrospinal fluid in the diagnosis of meningeal carcinomatosis].
    Shi Q; Pu CQ; Wu WP; Huang XS; Yu SY; Tian CL; Huang DH; Zhang JT
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1192-4. PubMed ID: 20501426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The determination of medical reference values for tumor markers in cerebrospinal fluid].
    Shi Q; Pu CQ; Wu WP; Huang XS; Yu SY; Tian CL; Cao XT
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):355-6. PubMed ID: 19563718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The concentration of CYFRA 21-1, NSE and CEA in cerebro-spinal fluid can be useful indicators for diagnosis of meningeal carcinomatosis of lung cancer.
    Wang P; Piao Y; Zhang X; Li W; Hao X
    Cancer Biomark; 2013; 13(2):123-30. PubMed ID: 23838141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].
    Chen F; Li WM; Wang DM; Gao SS; Bao Y; Chen WB; Liu D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):832-5. PubMed ID: 19024326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
    Li CS; Cheng BC; Ge W; Gao JF
    Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited.
    Ma S; Shen L; Qian N; Chen K
    Cancer Biomark; 2011-2012; 10(3-4):155-62. PubMed ID: 22674301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reference intervals for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1.
    Yang J; Tang A; Ma J; Sun X; Ming L
    Scand J Clin Lab Invest; 2019; 79(1-2):71-74. PubMed ID: 30727773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum tumour markers in patients with chronic kidney disease.
    Xiaofang Y; Yue Z; Xialian X; Zhibin Y
    Scand J Clin Lab Invest; 2007; 67(6):661-7. PubMed ID: 17852811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
    Chen C; Chen LQ; Yang GL; Li Y
    Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conventional Tumor Markers in Cerebralspinal Fluid in Patients with Elevated Serum Tumor Markers and without Central Nervous System Malignant Diseases.
    Liu ZJ; Shi Q; Lu B; Zhang Z; Tian CL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):539-542. PubMed ID: 27825410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum tumor markers CEA, CYFRA21-1, and CA-125 are associated with worse prognosis in advanced non-small-cell lung cancer (NSCLC).
    Cedrés S; Nuñez I; Longo M; Martinez P; Checa E; Torrejón D; Felip E
    Clin Lung Cancer; 2011 May; 12(3):172-9. PubMed ID: 21663860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Seven Clinical Tumor Markers in Diagnosis of Non-Small-Cell Lung Cancer.
    Chen ZQ; Huang LS; Zhu B
    Dis Markers; 2018; 2018():9845123. PubMed ID: 30647803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
    Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T
    Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of leptomeningeal carcinomatosis: demonstration of CA19-9 and CEA positive malignant cells in the CSF and particular elevation of CA19-9 level in the CSF].
    Sato Y; Ohta Y; Ohtsuka T; Shoji H; Oizumi K
    Rinsho Shinkeigaku; 1991 Feb; 31(2):175-8. PubMed ID: 2060242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of C12 multi-tumor marker protein chip in the diagnosis of gastrointestinal cancer: results of 329 surgical patients and suggestions for improvement.
    Yang XQ; Yan L; Chen C; Hou JX; Li Y
    Hepatogastroenterology; 2009; 56(94-95):1388-94. PubMed ID: 19950797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer.
    Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH
    Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic value of multiple tumor marker detection for mature and immature teratoma of the ovary].
    Chen C; Li JD; Huang H; Feng YL; Wang LH; Chen L
    Ai Zheng; 2008 Jan; 27(1):92-5. PubMed ID: 18184473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
    Lai IR; Lee WJ; Huang MT; Lin HH
    Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis].
    Nakagawa H; Kubo S; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Hayakawa T
    No Shinkei Geka; 1991 Dec; 19(12):1135-41. PubMed ID: 1766538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.